Reduction Mammaplasty Linked to Improved HRQoL in Teens

Share this content:
Reduction Mammaplasty Linked to Improved HRQoL in Teens
Reduction Mammaplasty Linked to Improved HRQoL in Teens

FRIDAY, Oct. 6, 2017 (HealthDay News) -- For adolescents with macromastia, reduction mammaplasty is associated with significant improvements in health-related quality of life and breast-related symptoms, according to a study published online Oct. 6 in Pediatrics.

Laura C. Nuzzi, from Boston Children's Hospital, and colleagues administered the Short-Form 36v2 (SF-36), Rosenberg Self-Esteem Scale (RSES), Breast-Related Symptoms Questionnaire (BRSQ), and Eating Attitudes Test-26 to 102 adolescents with macromastia and 84 female controls (aged 12 to 21 years) in a longitudinal cohort study. Surveys were completed by patients with macromastia preoperatively and at six months and one, three, and five years after reduction mammaplasty; controls completed surveys at the same intervals.

The researchers found that significant score improvements were demonstrated postoperatively from baseline on the RSES and on the BRSQ, and in seven of eight SF-36 domains (physical functioning, role-physical, bodily pain, vitality, social functioning, role-emotional, mental health) for patients with macromastia. Postoperative subjects scored similarly to or more favorably than controls on the RSES, BRSQ, Eating Attitudes Test-26, and SF-36 by the six-month follow-up visit; these benefits persisted for five years or more, with no significant impact by body mass index (BMI) category or age.

"Patients and providers should be aware of the potential positive impact that reduction mammaplasty can provide adolescents with symptomatic macromastia," the authors write. "Historic concerns regarding age and BMI category at the time of surgery should be reconsidered."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Extended-Release Naltrexone Promising for Opioid Dependence

Extended-Release Naltrexone Promising for Opioid Dependence

Lower use of heroin, other illicit opioids with extended-release naltrexone in superiority analysis

New Expert Consensus Pathway for Mitral Regurgitation

New Expert Consensus Pathway for Mitral Regurgitation

Etiology, mechanism, severity, indications for treatment should be assessed after MR is identified

Many Dermatology Guideline Authors Get Industry Payments

Many Dermatology Guideline Authors Get Industry Payments

22 of 40 guideline authors receiving payments did not accurately disclose industry relationships

is free, fast, and customized just for you!

Already a member?

Sign In Now »